July 09, 2008
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for December 10, 2004 Subscribe to this News Feed  
 

Vioxx Lawyers and Vioxx Recall Lawsuits

Download this press release as an Adobe PDF document.

Hundreds of affected consumers are now bringing cases against Merck, the maker of Vioxx.

(PRWEB) December 10, 2004 -- Over the past two months, there has been a large public outcry due to the prescription drug Vioxx. Many people who have taken the drug are having heart attacks, strokes and other serious medical problems. The drug was recalled after four years on the market, with billions of dollars in revenues for its manufacturer, Merck. Now the manufacturer faces a series of lawsuits and billions of dollars in claims.

Not surprisingly, people who have taken Vioxx are seeking legal representation for their Vioxx Claims. Vioxx recall lawyers, who's main practice falls under product liability law, are providing those who have been affected by Vioxx with answers to their legal questions. Did you know that analysts estimate that Merck's legal costs could reach $12 billion, and that their liability could be well over $17.6 billion over the next decade? Vioxx class action lawsuits have already been filed and Vioxx claim cases are being submitted by the thousands. If you have taken the drug and suffered a Vioxx heart attack or Vioxx stroke, then you could be a part of that compensation. There are many Vioxx side effects, so be sure and contact your doctor to be sure about your health.

Lawsuits have already been brought against Merck over their Vioxx drug. Some of these case are:

-Elizabeth Aiken v. Merck & Co. Inc., No. 04-CV08085, S.D. N.Y.
-Sidney Schneider v. Merck & Co. Inc., et al., No. 04-22632, S.D. Fla.
-Sharon Scott Jones v. Merck & Co. Inc., No. 04-3079, N.D. Ala.
-Robert V. Purcell v. Merck & Co. Inc., et al., No. 04-CV-2089, C.D. Calif.

In all, more than 375 Vioxx lawsuits are now awaiting trial against Merck. The story is the same in Europe, Canada, Brazil and Israel. For Merck, the legal stakes are high. The nightmare has just begun. It comes as no surprise then, that the company's stock lost 40% of its value overnight. Figures of 27,785 heart attacks and deaths from 1999 to 2003 were levelled at them. Merrill Lynch in Nov 2002, estimated that the company could be held responsible for as high an amount as $18 billion which could include $15.3 billion compensation for serious cardiovascular damages, $1 billion to $2 billion for "nuisance" case events and $1 billion incurred in litigation-related expenses. More than a 1,000 Victims groups hold Merck morally and legally responsible for personal injuries due to the use of Vioxx. Certain Vioxx lawyers, in their lawsuits, even allege gastrointestinal bleeding, cardiovascular events and kidney damage.

Many of those people who have been affected by Vioxx are turning to the internet to connect with legal counsel. LegalServicesInfo.com connnects people who have taken Vioxx and had a serious side effect with a Vioxx lawyer. Those who would like to join a Vioxx lawsuit or Vioxx class action can easily be matched up with a Vioxx attorney and be represented.

About LegalServicesInfo.com
LegalServicesInfo matches up people who have been affected by Vioxx with Vioxx lawyers, Vioxx attorneys and Vioxx law firms. If you are one of the millions of people who have taken Vioxx and are concerned with Vioxx side effects, contact Vioxx law firm today.

###


This press release was posted by the following PR Firm
Regency Marketing (View Listing in Directory of PR Firms)
 
Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
John Dalton
REGENCY MARKETING
561-499-3329
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PR Web™. We will be unable to assist you with your inquiry.
PR Web™ disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2005, PRWeb™. All Rights Reserved

Terms of Service | Privacy Policy